Hmmm slightly flawed logic there. It currently doesn't have a dollar figure attached to it because it needs to be negotiated by the global branches of Compass. It will be worth as much as each Compass branch thinks is necessary to cover their staff. We have a preliminary deal that opens distribution routes within the broader company. That carries value.
Ann: FDA Strategy and Regulatory Update, page-514
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
